Aktuelle Publikationen / recent publications

Key publications

Wree A, Eguchi A, McGeough MD, Pena CA, Johnson CD, Canbay A, Hoffman HM, Feldstein AE. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation and fibrosis. Hepatology. 2014 Mar;59(3):898-910.

Wree A, McGeough MD, Peña CA, Schlattjan M, Li H, Inzaugarat ME, Messer K, Canbay A, Hoffman HM, Feldstein AE. NLRP3 Inflammasome Activation is required for Fibrosis Development in NAFLD. J Mol Med (Berl). 2014 Oct;92(10):1069-82.

Wree A, Johnson CD, Font-Burgada J, Eguchi A, Povero D, Karin M, Feldstein AE. Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation. Cell Death Differ. 2015 Apr 24.

Wree A, Broderick L, Canbay A, Hoffman HM, Feldstein AE. From NAFLD to NASH to Cirrhosis – new insights into disease mechanisms. Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):627-36

Eguchi A, Wree A, Feldstein AE. Biomarkers of liver cell death. J Hepatol. 2014 May;60(5):1063-1074.

 

For a more comprehensive list of publications, please click on the following PubMed-link.